Ending Discrimination in COVID–19 Treatments Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Ending Discrimination in COVID-19 Treatments Act
This bill prohibits consideration of certain factors, including vaccination status, in decisions about an individual's access to federally provided monoclonal antibody therapies to treat COVID-19.
As a condition of receiving the therapies from the federal government, states must ensure that providers do not consider specified demographic characteristics, veteran status, or political ideology or speech when determining a patient's eligibility for such therapies.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 3974: Ending Discrimination in COVID–19 Treatments Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-3974/
"S. 3974: Ending Discrimination in COVID–19 Treatments Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-3974/.
S. 3974, 117th Cong. (2026), https://openamerica.io/bill/117-S-3974/.
[S. 3974: Ending Discrimination in COVID–19 Treatments Act](https://openamerica.io/bill/117-S-3974/)